The study was registered in the Nederlands Trial Register on Patient request or unexpected need for an inhalation induction due to significant difficulties to obtain intravenous access and any procedural events requiring endotracheal intubation were defined as secondary exclusion parameters.
| Study procedures
Standard sedation monitoring equipment according to departmental standards (ECG, pulse oximetry, noninvasive blood pressure, and qualitative CO 2 sampling via a nasal cannula) was used.
Before initiation of sedation, all study patients were attached to a Narcotrend TM EEG monitor (MT MonitorTechnik GmbH & Co. KG, Bad Bramstedt, Germany) according to the manufacturer's specifications. The Narcotrend records the frontal EEG to calculate a dimensionless index of depth of hypnosis, the Narcotrend Index, ranging from 0 (very deep hypnosis) to 100 (being fully awake). The Narcotrend monitor records the EEG using 3 conventional ECG electrodes and does not require device-specific EEG electrodes.
Narcotrend data were exported as Excel files for subsequent analyses using the EEG Viewer TM software package (Version 1.6, MT
MonitorTechnik GmbH & Co. KG, Bad Bramstedt, Germany).
Propofol was administered using the Paedfusor TCI model 10 on
an Alaris TM PK Syringe Pump (CareFusion UK 306 Ltd, Basingstoke, UK). The total amount of propofol (mg) infused during the endoscopy was noted for subsequent analysis.
What is already known about the topic
• Reliable continuous and nondisruptive assessment of the depth of hypnosis during propofol sedation in pediatric patients is challenging.
• Processed electroencephalography using the Narcotrend Index of depth of hypnosis can help titrating propofol to a desired sedation level during pediatric gastrointestinal endoscopy.
What new information this study adds
• Narcotrend Index guidance of propofol delivery results in significantly shorter recovery times, less drug consumption, and fewer episodes of oversedation than standard practice.
Sedation was initiated using a stepwise increase (1 lg/mL) of propofol every 15 seconds, until either a stable Narcotrend Index of 65 AE 5 (Group NI), or a state of deep sedation, with the patient not being rousable by mild tactile stimulation (Group C), was established.
When these milestones were reached, the endoscopy was allowed to be started.
During the endoscopy, in patients randomized to group NI, propofol was titrated in steps of 0.5 lg/mL to maintain a Narcotrend Index of 65 AE 5. We had to take care to keep the likelihood of unintended episodes of intraprocedural awareness with recall as low as possible.
Therefore, and due to personal clinical experience of the principle investigator, we aimed at NI values indicating a rather deep level of sedation. 11 We are aware that it is debatable whether our approach should be called deep sedation or light anesthesia with an unsecured airway. The latter definition might confuse readers; therefore, we decided to call our approach procedural sedation and analgesia.
In patients randomized to group C, Narcotrend Index data were unavailable to the pediatric anesthesiologist in charge. Propofol dosing was entirely based on conventional clinical surrogate parameters of depth of hypnosis, such as heart rate, blood pressure, and patient movement. The same 0.5 lg/mL titration steps as in group NI were applied to achieve and maintain good endoscopy conditions.
Remifentanil was infused starting at a continuous rate of 0.025 lg/kg/min, irrespective of study group allocation. In case of clinical signs of discomfort or purposeful movement, remifentanil infusion was increased to 0.05 lg/kg/min, whereas in the event of a respiratory rate of ≤10/min, the infusion rate was lowered to 0.01 lg/kg/min.
Patients were breathing spontaneously throughout the sedation procedure, having oxygen 3 L/min applied via a nasal cannula.
Immediately after removal of the endoscope at the end of the procedure, anesthetic drug infusions were discontinued. An investigator who was blinded to patient group allocation entered the operating room and started to assess the patients' course of recovery from procedural sedation using the "Steward Recovery Score from Anaesthesia". 12 Predefined criteria for discharge from the operating room to the recovery room were responsiveness to stimulation, good airway maintenance, and nonpurposeful movements, equaling to a Steward score of 3 out of 6. The time interval between discontinuation of propofol delivery and reaching a Steward score of 3 was defined as the primary outcome parameter of this trial.
The following secondary outcome parameters were defined:
Propofol consumption (mg/kg/h) during the endoscopy, the time interval between the end of the procedure and meeting discharge | 445 criteria from the recovery room (Steward score of 6), the distribution of Narcotrend Index values during the endoscopy (within, below, or above the target range of 65 AE 5), the incidence of recall of events during the endoscopy (assessed by a Brice interview 13 on 3 occasions), the assessment of the endoscopy conditions by the pediatric gastroenterologist (good-acceptabledifficult) and adverse effects. We had also planned an economic analysis (cost minimization analysis). Unfortunately, due to legal restrictions regarding the publication of economic data, which we
were not aware of when we designed this study, we were unable to perform that analysis.
| Randomization
Patients were allocated to the intervention or the control group according to a block-randomization scheme (6-8-8-8-10 = 40), generated by the principle investigator (F.W.) using the website Randomization.com (http://www.randomization.com). F.W. was the anesthesiologist who delivered procedural sedation to all study patients and was therefore not blinded regarding patient allocation to study groups.
| Power analysis
To detect a difference of 30% less time to meet discharge criteria from the operating room (Steward Score of 3) in the intervention group, with an alpha level of significance fixed at .05 and a beta level of .20, the number of patients required in each study group was 18. This expected difference was based both on previously published data in patients undergoing procedures under general anesthesia 11 or sedation 14 and personal experience of the principle investigator (F.W.) of this study. In order to compensate for possible dropouts due to any kind of protocol violation, a sample size of 2 9 20 study patients was chosen. Sample size was calculated both for both a Student's t test (n = 2 9 17 subjects) and a Mann-Whitney U test (n = 2 9 18 subjects) using G*Power 3.1. 15 
| Statistical analysis
Data analysis was performed by all authors using Prism 7 for Mac OS X (Version 7.0C, GraphPad Software Inc., La Jolla, CA, U.S.A. There were no episodes of hypoxia in any patient. We observed the following adverse events, all during the induction period, prior to the start of the endoscopy: A jaw-thrust maneuver was required in 1 patient in group NI and 1 patient in group C. Four patients in group C required face mask ventilation, all of them for less than 1 minute.
| DISCUSSION
The results of this study, comparing recovery times from procedural sedation and analgesia for pediatric gastrointestinal endoscopy using either EEG-directed propofol delivery or standard practice, provide evidence of the additive value of Narcotrend Index monitoring on the speed of recovery. This applies to meeting discharge criteria from both the operating room (5.4 vs 10.2 minutes) and the recovery room (8.1 vs 11.1 minutes). The accumulated decrease in discharge time from the operating room during an entire endoscopy list could be sufficient to include an additional short procedure.
We used TCI technology for propofol application. propofol is injected slower than a usual manual induction bolus, which helps to maintain spontaneous ventilation. 18 Powers et al 14 Oversedation may be associated with cardiorespiratory compromise, whereas under-sedation can cause intraprocedural awareness with recall. During PSA with an unsecured airway, which, in patients undergoing esophagogastroduodenoscopy is even inaccessible without interrupting the procedure, airway compromise due to hypoventilation is a significant safety issue, as opposed to patients under general anesthesia, having their airway secured by an endotracheal tube or a laryngeal mask. In our study, we did not encounter these adverse events in any of our patients.
| Patient safety aspects
There is an ongoing debate about safety issues associated with deep sedation for pediatric gastrointestinal endoscopy. [4] [5] [6] [19] [20] [21] [22] This debate is about drug safety, patient selection, care givers' competencies, and institutional issues. What our results add to the drug safety discussion is that Narcotrend Index-guided dosing of propofol, using TCI technology, results in a significant reduction of episodes of undesired oversedation, compared to conventional treatment protocols. Though we strongly recommend our concept of deep sedation for pediatric GE, using Narcotrend-guided propofol delivery, aug- This study was conducted in pediatric patients aged 12-17 years.
There is sufficient evidence from the scientific literature that processed EEG provides us with reliable information regarding the DoH in this patient age group. 23, 24 Care must be taken not to extrapolate the results of this study to significantly younger children or even infants. This is both due to the fact that young age is a known risk factor when delivering PSA, 19 and maturational aspects of the EEG, which make DoH monitors less reliable in young children.
23,24
| Shortcomings
Using DoH monitoring to titrate hypnotic drugs without feeling uneasy about relying on the information provided by the DoH monitor, needs at least some degree of experience in using that technology. In our study, sedation was given by a single pediatric anesthesiologist (F.W.), with long time experience in using DoH monitoring in children. As already mentioned by Roizen and Toledano, 25 being accustomed to the use of certain technology in a certain group of patients improves outcomes in all patients. There is thus a chance that propofol dosing in the control group was slightly influenced by a "sub-conscious" influence of the experience derived from using DoH monitoring in other patients before. To minimize the chance of learning-contamination bias, patients randomized to group NI should their sedation preferably have been given by an anesthesiologist accustomed to the use of the Narcotrend, whereas the anesthesiologist responsible for patients randomized to group C should have no experience at all in the use of DoH monitoring. Unfortunately, we did not have enough research staff available to perform the study that way.
It would have added significance to the results of our study if we had effect site concentration TCI models available for both propofol and remifentanil. Unfortunately, the plasma concentration Paedfusor model is currently the only TCI algorithm registered for use in pediatric patients in the Netherlands.
| CONCLUSION S
In this prospective randomized controlled study, conducted in pedi- 
